Evidence map›Paper›PMID 40264725›Full record

ArticleWomen (Basel, Switzerland)2025

Insights into Perimenopause: A Survey of Perceptions, Opinions on Treatment, and Potential Approaches.

Andrea K Wegrzynowicz, Amanda C Walls, Myra Godfrey, Amy Beckley

Abstract read
In one paragraph

Article in Women (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea K WegrzynowiczDepartment of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI 53715, USA.ORCID 0000-0002-1493-4563
Amanda C WallsMFB Fertility, Boulder, CO 80301, USA.
Myra GodfreyJaya Jaya Myra Productions, New York, NY 10010, USA.
Amy BeckleyMFB Fertility, Boulder, CO 80301, USA.ORCID 0000-0003-3509-5866

Funding

Integrated Program in Endocrinology Translational Postdoctoral Training ProgramT32HD101384 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI IAN M. BIRD, Jon E Levine · 2021 to 2026
$2.0M
NICHD NIH HHS T32 HD101384
6 · The paper itself

Abstract

Perimenopause, the transitional phase leading up to menopause, affects millions of women worldwide, yet it remains poorly understood and under-addressed in healthcare. Despite the availability of treatment options like hormone replacement therapy (HRT) and non-hormonal alternatives, the awareness and utilization of these options vary significantly among women. Here, we conducted a cross-sectional survey with 1000 adults, both men and women, from the United States and Canada. We evaluated the perceived familiarity of participants with the timing, duration, and symptoms of perimenopause, as well as their satisfaction with their treatment options and communication with their healthcare providers. We found that, in general, women and older people were more likely to feel familiar with perimenopause, although the youngest age group surveyed also reported relatively high familiarity. We also found that there is a disconnect between people reporting high familiarity with perimenopause and its symptoms but overall middling and lower familiarity with the age and duration of onset and satisfaction with treatment options. Our results suggest further investigation into where people obtain their information concerning perimenopause, as well as into how knowledge of perimenopause may vary based on demographics.

Indexed as

healthcare communicationhormone replacement therapy (HRT)menopauseperimenopausesymptom managementwomen’s health

Identifiers

PMID40264725
PMCPMC12014197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.